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Risk of cigarette smoking on male fertility in  Gaza 
Governorate, Gaza Strip 
 
Abstract 
Background: Epidemiological studies have shown an association between 
smoking and increasing risk of male infertility. 
Aim: To assess the risk of cigarette smoking on male fertility in Gaza 
Governorate, Gaza Strip. 
Place of study: Specialized laboratories in Gaza Governorate, Gaza Strip. 
Time of study: From October, 2010 to June, 2011  
Subjects and Methods: The present case control study included 54 smokers  
(cases) and 54 non smokers (controls) matched with age. Data were collected 
by questionnaire interview, semen and hormonal analysis. Data were 
analyzed  using SPSS version 18. 
Results: The mean ages of controls and cases were 33.5±7.6 and 32.7±6.3 
years, respectively. The percentage of cases who had children was lower 
than controls (37.0% v 81.5%, P=0.000). The percentages of cases who had 
testes surgery, previous semen and hormone analysis were higher than 
controls (33.3% v 11.1%; 88.9% v 29.9% and 83.3% v 9.3%, P=0.005, 
P=0.000 and P=0.000, respectively). Passive smoking was significantly 
associated with male fertility (P=0.000). The majority of cases were cigarette 
smokers and around half of them smoked more than 20 cigarettes/day. In 
addition, more than half of the cases smoked for 5-15 years. The longer 
duration of smoking, the less number of cases having children (P=0.026). 
Smoking  had negative impact on sexual desire and erection in about quarter 
of cases. The mean sample volume, total count and active sperm were 
significantly decreased in cases compared to controls (2.7±1.3, 16.7±16.1 and 
22.0±16.3 v 4.1±1.9, 52.6±14.6 and 43.3±11.2, with P=0.004, P=0.000 and 
P=0.000, respectively), whereas the mean abnormalities and dead sperms 
were markedly increased (23.0±9.9 and 57.9±16.2 v 10.9±6.0 and 35.8±10.2, 
respectively, P=0.000). When semen parameters were related to the number 
of smoked cigarettes/day and duration of smoking, there was a significant 
decrease in the number of active sperms whereas dead sperms were 
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significantly increased with increasing the number of smoked cigarettes/day 
and smoking duration. In addition, total sperm count was significantly 
decreased only with increasing smoking duration. The mean levels of 
testosterone, luteinizing hormone (LH), follicular stimulating hormone (FSH) 
and prolactin in cases showed no significant decrease compared to controls. 
Also, the number of smoked cigarettes/day and duration of smoking had no 
significant effect on hormonal profile. 
Conclusions: Cigarette smoking affects fertility by its main negative impact 
on semen parameters rather than hormonal profile at least in our patients. 
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Fertility is the natural capability to produce offspring. As a measure, "fertility 
rate" is the number of children born per couple, person or population. The 
testes are the main male reproductive organs and are very important for the 
normal functioning of the male reproductive system. The regulation of the testis 
function is mediated primarily by two pituitary hormones under control of 
gonadotropin-releasing hormone (GnRH) from hypothalamus: Luteinizing 
hormone (LH) and follicular stimulating hormone (FSH). LH stimulates leydig 
cells to produce testosterone and FSH acts on Sertoli cells to stimulate 
spermatogenesis (Zirkin and Chen, 2000 and Haider, 2004). 
 
Human fertility depends on factors of nutrition, sexual behavior, culture, instinct, 
endocrinology, timing, economics, way of life, and emotions. There are also 
some other factors that have relative effect on male fertility like cigarette 
smoking (Kidd et al., 2001). Fertility does not decline in men as sharply as it 
does in women. There have been examples of males being fertile at 94 years 
old (Sherman, 1991).  
 
According to the World Health Organization (2002), approximately one-third of 
the worlds male adult population (above 15 years of age) smokes. The 
combustion of tobacco yields about 4000 chemical compounds, some of which 
are deadly toxic. Given that cigarette smoke contains more than 30 compounds 
known to be mutagens, or carcinogens such as" radioactive polonium, 
benzo(a)pyrine, dimethylbenz(a)anthracene, dimethylnitrosamine, naphthalene, 
and methylnapthalene" which have a direct deleterious effects on human 




Other chemical compounds in tobacco including nicotine and its metabolite 
cotinine which may lead to poor semen function and resultant infertility (Arabi 
and Shareghi, 2005). Cigarette smoke contains also carbon monoxide which 
may affect male reproduction via direct effect on the testicular function and 
spermatogenesis; this mechanism may involve the hormonal control of 
spermatogenesis or via direct effect upon the germ cells and Sertoli cells of the 
seminiferous epithehum. Such alterations may lead to infertility and/or 
production of mutated spermatozoa which may subsequently cause an adverse 
pregnancy outcome if the mutated spermatozoa were to fertilize an egg 
(Hanrahan et al., 1996). Difficulties in getting pregnant may be from the effects 
of the nasty chemicals in cigarette smoke that affect the man's sperm and libido 
(Quitters Guide, 2008). 
 
The rate of smoking in the Palestinian territories is among the highest in the 
world compared to the other population. The prevalence of smoking in Gaza 
Strip was estimated to be 13.7% (The Palestinian Central Bureau of Statistics, 
2007). Sear smokers annually in the West Bank and Gaza are approximately $ 
450 million. The number of deaths caused by smoking each year in the West 
Bank and Gaza Strip, at least 4 thousand deaths (Statistics Of Smoking in Gaza 
Strip, Tahady.Com, 2006). 
 
The subject of possible detrimental effects of cigarette smoking on reproductive 
performance and specifically on semen parameters in the male is of great 
interest (Wong et al., 2000; Ramlau-Hansen et al., 2007 and Coelho et al., 
2009). But the data available are somewhat inconclusive. Despite the increased 
number of smokers in the Gaza Strip, particularly in young adulthood there was 
no study link between smoking and fertility in men. This will be the first study to 
investigate risk evaluation of cigarette smoking on male fertility in Gaza 
Governorate, Gaza Strip 
 
1.2 General objective 
The general objective of the present study is to assess the risk of cigarette 
smoking on male fertility in Gaza Governorate, Gaza Strip.  
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1.3 Specific objectives 
1. To assess the impact of smoking on semen parameters including volume, 
total count, abnormalities and motility. 
2. To estimate the effect of smoking on testosterone, FSH and LH and prolactin 
hormones. 
3. To find out possible relations between number of cigarette/day in relation to 
semen parameters and hormonal profile of smokers. 
4. To investigate possible relations between duration of smoking in relation to 
semen parameters and hormonal profile of smokers. 
 
1.4 Significance 
1. Smoking is a global problem and there are deficiency in health education 
programs to determine risk of smoking on fertility.  
2. The rate of smoking in the Palestinian territories is among the highest in the 
world compared to the other population. The prevalence of smoking in Gaza 
Strip was estimated to be 13.7%.  
3. Cigarette smoking has become a serious health and social problem today in 
Gaza Strip.  


















The primary reproductive organs of the male are the testes, or male gonads, 
which have both an exocrine (sperm producing) function and an endocrine 
(testosterone producing) function. The accessory reproductive structures are 
ducts or glands that aid in the delivery of sperm to the body exterior or to the 
female reproductive tract.   
 
2.1 Structure of testis 
The testis consists of convoluted seminoferous tubules embedded in a 
connective tissue matrix that called interstitium (Figure 2.1). The interstitium 
contains mixture of blood and lymph vessels, nerves, fibroblast cell, 
macrophages and Leydig cells. The epithelium of seminiferous tubules consists 
of continually dividing germ cells that produce sperm cells and supporting 
Sertoli cells. The sperm travel from the seminiferous tubules to the rete testis 
located in the mediastinum testis, to the efferent ducts, and then to the 
epididymis where newly-created sperm cells mature. The sperm move into the 
vas deferens, and are eventually expelled through the urethra and out of the 
urethral orifice through muscular contractions (Krohmer, 2004). 
 
 
Figure 2.1. cross-section of the testis showing sperm producing tube (seminiferous tubule) and 
leydig cell (www.octc.kctcs.edu/GCaplan/anat2/notes/male.jpg) 
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2.2 Sperm formation (spermatogenesis) 
Spermatogenesis represents the entire process of germ cell development within 
the seminiferous epithelium of the adult testis. It can be divided into four phases 
and includes:  
2.2.1 Proliferation and differentiation of spermatogonia 
Spermatogonia are the diploid stem cells of spermatogenesis, and can be 
divided into type A and type B (Figure 2.2). Type A spermatogonia are further 
divided into A1-A4 spermatogonia (Steger et al.,1998). Type B spermatogonia 
are able to differentiate and enter the process of meiosis. 
 
2.2.2 Spermatocytes/Meiosis 
2.2.2.1 Primary and secondary spermatocytes 
Primary spermatocytes undergo the first meiotic division. The prophase of the 
first meiotic division takes about 13 weeks and is divided into several stages: 
the leptotene, zygotene, pachytene and diplotene stages. Secondary 
spermatocytes undergo the second meiotic division after a short interphase of 
about 6 h in the human without DNA synthesis. By this division, chromatids  are 




The transformation of conventional round cell spermatids into spermatozoa with 
the capacity for motility and fertilization of an egg includes a complex sequence 
of events: (1) formation of the acrosome, (2) condensation of the nucleus, (3) 
development of the sperm tail, (4) reorganization of cellular organelles such as 
mitochondria and centrioles and (5) reduction of the cytoplasm (Bermudez et 









Figure 2.2 Sperm formation (spermatogenesis) 






2.2.4 Spermatozoon  
The length of the human spermatozoon measures about 60 ìm. The flat and 
oval head (diameter: 3 ìm, length: 5 ìm) consists of the acrosome and the 
extremely condensed nucleus (Figure 2.3). The acrosome covers the head 
surface, and contains numerous proteolytic enzymes. The release of these 
enzymes, the so-called acrosome reaction, enables the spermatozoon to 
penetrate the corona radiata of follicle cells and the zona pellucida of the egg. 
The flagellum measures about 55 ìm in length. It possesses the central 
axoneme and is divided into (Henkel et al., 1994): 
■ The neck/connecting piece (1 ìm) is the point of articulation between the 
sperm head and the flagellum. 
■ The mid-piece (6 ìm) contains the mitochondria and the nine doublets of 
microtubules, which are associated with outer dense fibers. Outer dense fibers 
are believed to maintain the passive elastic structure for flagellar bending and 
also to protect it from shearing forces during epididymal transit and ejaculation 
(Baltz et al., 1990).  
■ The principal piece (45 ìm) is a fibrous sheet. 
■ The end-piece (5 ìm) only contains microtubules. Spermatozoa acquire 
motility during epididymal passage and their competence for fertilization during 













Figure 2.3 Schematic drawing of the human spermatozoon 
                                        (www.genericlook.com/anatomy/Spermatozoa/) 
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2.3 Semen parameters  
2.3.1 Semen volume    
Normal ejaculate volume is between 2 and 6 ml. 65% of the volume is from 
seminal vesicles, 30-35% is from the prostate and only 5% from the vasa. Low 
volume is associated with absence or decrease of seminal vesicle component 
of ejaculate or retrograde ejaculation (Irvine et al., 1994).  
2.3.2 Sperm concentration 
Sperm concentration refers to the number of sperm found in a measured 
quantity of semen. Normospermic specimen contains more than 20x106 sperms 
(World Health Organization, WHO, 1992). 
2.3.3 Sperm motility  
Sperm motility refers to the swimming capabilities of the sperm. If sperm cannot 
swim properly, they may have trouble reaching the egg and fertilizing it. 
Normally >50% of sperm in the specimen are motile (Irvine, 1995). 
2.3.4 Sperm morphology  
Sperm morphology refers to the shape of sperm. Oddly shaped sperm may not 
swim well enough to get to the egg and may not be able to fertilize an egg. 
Strict criteria for normal sperm morphology include (Bernstein et al., 1995): 
-Sperm head: Smooth oval configuration. Length-5-6 microns. Width:2.5-3.5 
microns. 
- Acrosome comprises 40-70% of the anterior sperm head. 
- Midpiece: Axially attached, 1.5 times the head length, ≤1m in width.  
- Tail: Straight, uniform, slightly thinner than the midpiece, uncoiled, ± 45m 
long.  
 
2.4 Male fertility hormones 
2.4.1 Testosterone  
Testosterone is a male sex hormone, secreted by Leydig or interstitial cells of 
the testes in the male and by the follicular theca and interstitial cells of the 
ovaries in the female. Testosterone secretion is regulated by negative feedback 
of testosterone on the release of luteinizing hormone (LH) from the pituitary 
gland. Testosterone is highly protein-bound. In males, 98% of the testosterone 
9 
 
in circulation is bound; the value is slightly lower in females. The majority of the 
steroid is bound to a specific binding protein, sometimes referred to as sex 
hormone binding globulin (SHBG) or testosterone binding globulin (TeBG), and 
to serum albumin (Dunn et al., 1981).  
 
2.4.2 Follicle stimulating hormone (FSH) and luteinizing 
hormone (LH) 
Human FSH is a glycoprotein of approximately 30,000 daltons which, like LH, 
human chorionic gonadotropin (hCG) and thyroid stimulating hormone (TSH), 
consists of two noncovalently associated subunits designated  and (Pierce 
and Parsons, 1981). The  subunit of FSH contains 92 amino acids and is very 
similar to the  subunits of LH, hCG, and TSH. The  subunit of FSH is unique 
and confers its immunological and functional specificity.  
 
FSH and LH control growth and reproductive activities of the gonadal tissues 
(Catt and  Pierce, 1978 and Daughaday, 1985). FSH promotes follicular 
development in the ovary and gametogenesis in the testis (Franchimont, 1973 
and Catt and Pierce, 1978). The gonadotroph cells of the anterior pituitary 
secrete both FSH and LH in response to gonadotropin releasing hormone 
(LHRH or GnRH) from the medial basal hypothalamus (Bonnar, 1973). Both 
FSH and LH are secreted in a pulsatile manner, with rapid fluctuations over the 
normal range (Catt, 1978 and Crowley et al., 1987 and Beastall  et al., 1987). 
The pulsatility of FSH is less pronounced than that of LH. Release of both FSH 
and LH from the pituitary is under negative feedback control by the gonads 
(Bonnar, 1973).  
 
In males, FSH, LH, and testosterone regulate spermatogenesis by the Sertoli 
cells in the seminiferous tubules of the testes. FSH is less sensitive to feedback 
inhibition by testosterone than is LH and is thought to be regulated 
independently by the inhibitory peptide inhibin produced by the Sertoli cells 
(Jeffcoate, 1975 and Griffin and Wilson, 1985). Because of the negative 
feedback mechanisms regulating gonadotropin release, elevated concentrations 
of LH and FSH are indicative of gonadal failure when accompanied by low 
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concentrations of the gonadal steroids. In males, these observations suggest 
primary testicular failure. FSH may also be elevated in Klinefelters syndrome 
(seminiferous tubule dysgenesis) or as a consequence of Sertoli cell failure 
(Franchimont, 1973). 
 
2.4.3 Prolactin hormone 
Human prolactin (hPRL) is a single chain polypeptide of 199 amino acids and a 
molecular weight of approximately 23,000 daltons. Its existence as a distinct 
chemical entity, separate from growth hormone, was established through a 
series of studies between 1965 and 1971 (Frantz, et al.,1972 and Niall, 1972). 
Prolactin is produced by the anterior pituitary and its secretion is regulated 
physiologically by inhibitory (Talwalker, et al., 1963) and releasing (Bowers, et 
al., 1971) factors of the hypothalamus. Prolactin appears in the blood promptly 
after administration of thyrotropin-releasing hormone (TRH) (Friesen, et al., 
1972). 
 
The major physiologic action of prolactin is the initiation and maintenance of 
lactation in women. Hyperprolactinemia has been established as a common 
cause of infertility and gonadal disorders in men and women. Prolactin has 
been shown to inhibit the secretion of ovarian steroids (Demura, et al., 1982 
and Kauppila, et al., 1982) and to interfere with follicle maturation and the 
secretion of LH and FSH  (Andersen, et al., 1982) in the human female. 
Measurement of elevated serum prolactin levels may provide the first 
quantitative evidence of pituitary dysfunction (Franks, et al., 1977).  Quantitation 
of prolactin levels is also of interest in the evaluation and management of 










2.5 Interrelationships between the hypothalamus, 
pituitary and testis  
The successful initiation of testicular function is dependent on the hypothalamic 
secretion of GnRH which in turn stimulates FSH and LH to act on the testis 
(Schanbacher, 1982). These actions initiate spermatogenesis and testosterone 
production. The testis in turn, through the secretion of hormones produced in 
the Sertoli and Leydig cells, exerts a negative feedback control on the 
production of gonadotrophins (Griswold, 1998). 
 
2.5.1 Control of LH secretion  
There is a substantial body of evidence to indicate that the steroid hormones 
testosterone, estradiol and dihydrotestosterone inhibit LH secretion. From the 
studies by (Santen and Bardin, 1973), it is evident that testosterone acts at the 
hypothalamic level by decreasing GnRH pulse frequency without a change in 
pulse amplitude. However, the action of estradiol appears to be predominantly 
at the pituitary where it decreases LH pulse amplitude without changing pulse 
frequency. Further support for the action of testosterone at the hypothalamus 
emerged from the observation of a decrease in GnRH pulse frequency in portal 
blood (Kretser, 2002). 
 
2.5.2 Control of FSH Secretion  
There is a substantial body of evidence to indicate that testosterone and 
estradiol are capable of suppressing FSH in the male (Hayes et al., 2001). For 
many years, it was proposed that the action of the steroid hormones could 
account for the entire negative feedback exerted on FSH levels by the testis 
despite the existence of a hypothesis that a specific FSH feedback regulator 








2.6 Smoking and male fertility 
Attia et al. (1989) compared serum levels of estradiol (E2), prolactin (PRL), and 
total testosterone (T) in 50 heavy smokers (median 23.5 cigarettes/day) and 35 
men who never smoked. The median age was 25.4 years among smokers and 
27.4 years among nonsmokers. The differences between these 2 groups of 
men in terms of E2 and PRL levels were significant. Smokers showed elevated 
E2 levels (median, 59.8±1.83 pcg/ml) compared with nonsmokers (median, 
48.6±0.9 pcg/ml) (P=0.001). The median serum PRL level was 10.11±0.55 
ng/ml in smokers compared with 7.88±0.54 ng/ml in nonsmokers (P=0.001). 
The median level of serum T did not differ significantly between smokers 
(4.53±0.17ng/ml) and nonsmokers (4.55±0.24 ng/ml).  
 
Field et al. (1994) examined the relationship of cigarette smoking to serum 
dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), 
androstenedione, cortisol, testosterone, albumin-bound testosterone, free 
testosterone, dihydrotestosterone (DHT), and sex hormone-binding globulin 
(SHBG) in 1241 randomly sampled middle-aged U.S. men. Compared with 
nonsmokers and independent of relative weight and age, cigarette smokers had 
increased serum levels of DHEA (18% higher, P=0.0002), DHEAS (13% higher, 
P=0.0007), cortisol (5% higher, P=0.01), androstenedione (33% higher, 
P=0.0001), testosterone (9% higher, P=0.009), DHT (14% higher, P=0.004), 
and SHBG (8% higher, P=0.004).  
 
A cross-sectional study was conducted to determine the semen parameters of 
proven fertile males in Singapore and compare it with the World Health 
Organization (WHO) recommended normal values and to examine some factors 
that may affect spermatogenesis (Chia et al., 1998). A total of  243 men, whose 
wives were pregnant at the time of collection of semen, provided a semen 
sample each after sexual abstinence for 3 days. A questionnaire was used to 
elicit occupational exposure, alcoholic consumption, smoking history and past 
significant medical history. Most subjects had normal sperm volume (56.4%), 
concentration (79.8%), motility (69.5%) and viability (53.5%) based on WHO 
criteria. However, fertile men had a low mean percentage of normal sperm 
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morphology (20.0%), although they were normally distributed. Cigarette 
smoking was associated with significantly lower semen volumes even after 
adjusting for alcohol consumption. The WHO criterion for normal sperm 
morphology is too stringent, and should be adopted with caution.  
 
Wong  et al. (2000) evaluated the impact of cigarette smoking on male factor 
subfertility and the semen parameters of sperm count, motility, and morphology 
by questionnaire and determination of the cotinine concentrations in blood and 
seminal plasma of fertile and subfertile males. A total of 107 fertile and 103 
subfertile males from Netherlands provided a standardized blood and semen 
specimen and completed a self-administered questionnaire about their smoking 
habits. A higher frequency of cigarette smoking was observed in subfertile 
males than in fertile males, with an odds ratio of 1.7 (95% confidence interval, 
0.9-3.2). The self-reported number of cigarettes smoked per day correlated with 
the cotinine concentrations in blood and seminal plasma for both groups. A 
small but statistically significant correlation was found between cotinine 
concentrations in seminal plasma and the percentage of abnormal sperm 
morphology, but not for other semen parameters. 
 
The effect of smoking on the semen quality in infertile men in China was studied 
(Zhang et al., 2000). Adult non-drinker males attending the infertility clinic, 
including 110 non-smokers and 191 smokers, were recruited for the study. 
Sixty-one fertile, non-smoker and non-drinker males, who had one or more 
children, served as the controls. The semen volume, acidity, sperm density, 
viability and forward progression, as well as the seminal plasma contents of Zn, 
Cu and SOD were much lower in the medium, heavy and long-term smokers 
than in the non-smokers (P<0.01). The sperm density, viability and forward 
progression, and the seminal plasma Zn, Cu and SOD levels were negatively 
correlated with the amount  and duration of cigarette smoking (P<0.01).   
 
English et al. (2001) determined whether smoking affects the level of 
bioavailable testosterone. A case-control study of 25 healthy male smokers and 
25 healthy never-smokers, matched by age and body mass index was carried 
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out. Early morning levels of total, free and bioavailable testosterone, 17beta-
oestradiol, sex hormone binding globulin (SHBG) and cotinine were determined 
and compared between the two groups. Levels of total (18.5±4.6 nM versus 
15.1±4.9 nM, P=0.01) and free testosterone (462±91 pM versus 402±93 pM, 
P=0.03) were found to be higher in smokers compared with non-smokers 
respectively, as was SHBG (34.1±12.8 versus 28.1±9.0 nM, P=0.06). There 
were no significant differences in the levels of bioavailable testosterone 
(3.78±1.59 versus 3.51±1.26 nM, P=0.49) or 17beta-oestradiol (44.5±11.4 
versus 42.3±11.5 pM, P=0.50) between smokers and non-smokers respectively. 
These data suggest that cigarette smoking has no significant effect on the 
biologically active fraction of testosterone, but may influence the levels of total 
and free testosterone through changes in the levels of SHBG. 
The role of smoking on the risk of erectile dysfunction (ED) using data from a 
cross-sectional study on prevalence and risk factors for ED in 2010 Italian men 
aged more than 18 years were analyzed (Mirone et al., 2002). In comparison 
with never smokers, current smokers had an odds ratio (OR) of ED of 1.7 (95% 
confidence interval (CI), 1.22.4) and ex-smokers of 1.6 (95% CI, 1.12.3). The 
association between smoking and ED risk was present in subjects without a 
history of any cardiovascular disease, cardiopathy, hypertension, diabetes and 
neuropathy, but not in those with a history of these conditions. For example, the 
ORs of ED in smokers, in comparison with never smokers, were respectively 
2.4, 2.0 and 1.7 in men with no history of any cardiovascular disease, diabetes 
and neuropathy, but respectively 1.0, 1.0 and 1.2 in those with a history of the 
conditions. 
In a cohort study Künzle et  al. (2003) investigated the effect of cigarette 
smoking on main sperm variables in 655 smokers and 1,131 nonsmokers 
attending the andrology laboratory in the context of infertility investigation in the 
couple in Switzerland. Cigarette smoking was associated with a significant 
decrease in sperm density (−15.3%), total sperm count (−17.5%), total number 
of motile sperm (−16.6%), and citrate concentration (−22.4%). The percentage 
of normal forms was significantly reduced in smokers, and sperm vitality, 
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ejaculate volume, and fructose concentration were slightly but non significantly 
affected.  
 
In a prospective study Taszarek-H et al. (2005) investigated different semen 
parameters of infertile smokers with a history of cigarette smoking in Poland. 
Twenty seven infertile men who smoked cigarettes, 79 infertile men who were 
nonsmokers and 82 healthy nonsmoking donors were evaluated. Smokers had 
significantly less spermatozoa with motility grade B (9.37% versus 11.9%, 
P<0.05), decreased results of hypoosmotic swelling test (46.39% versus 
52.11%, P<0.05) than nonsmokers infertile men. The concentration of 
leukocytes in semen was significantly higher in smokers (0.26 mln/ml versus 
0.11 mln/ml, P>0.05), which can also suggests oxidative imbalance in the 
ejaculates of these men. No differences were found in the assessment of sperm 
concentration, motility grade A, C, D, percentage normal forms and different 
sperm defects, induced acrosomal reaction and acidic aniline blue staining test 
between these two groups (P>0.05). Our data demonstrate that cigarette 
smoking alters semen quality which could worsen fertilizing capability in infertile 
men. 
 
Hosseinzadeh et al. (2007) assessed the effect of cigarette smoking on sperm 
parameters both before and after swim-up. Semen sample provided from fertile 
smoker (n=25), fertile nonsmoker (n=21), infertile smoker (n=23) and infertile 
nonsmoker men (n=32). Semen analysis was performed manually according to 
the World Health Organization Standards Guidelines. Results showed that 
sperm parameters quality in smoker men was approximately lower than 
nonsmoker men and that cigarette smoking has dose dependent effect on 
sperm parameters, but this effect was not significant. Therefore, it appears that 
cigarette smoking is associated with reduced sperm quality and the risk of 
idiopathic male infertility in smoker men. 
 
The association between current smoking and semen characteristics and 
hormonal levels in a large group of healthy men was studied (Ramlau-Hansen 
et al., 2007). From 1987 to 2004, seven separate occupational or environmental 
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semen quality studies were co-ordinated. A total of 2562 men participated, each 
providing semen and blood sample and answering a questionnaire about 
lifestyle and factors related to health. Appropriate semen and smoking data 
were available for 2542 men. Adjusting for study, age and other covariates, an 
inverse doseresponse relation between smoking and semen volume, total 
sperm count and percentage motile sperm was observed. Heavy smokers had a 
19% lower sperm concentration than non-smokers. A positive doseresponse 
relationship between smoking and testosterone, LH and the LH/free 
testosterone ratios was found.  
 
In a retrospective comparative study Coelho et al. (2009) analyzed the effects of 
cigarette consumption on semen parameters of 327 men in Portugal. The 
semen parameters were first compared between smokers and nonsmokers and 
then a heavy smokers/light smokers analysis took place. A total of 135 (41%) 
were smokers and 55 (40.7%) were heavy smokers. The demographic 
characteristics were similar between groups. The tobacco use was associated 
with an increased incidence of oligo/zoosperm, without difference in the other 
semen parameters. It was also noted a negative correlation between heavy 
smoking habits and semen volume abnormalities.  
 
Collodel et al. (2009) investigated whether smoking cigarettes increases the 
effect of varicocele on sperm morphology. The semen quality of 2 groups of 
patients with varicocele were compared, those who smoked (n=121) and those 
who did not (n=158). The semen parameters were evaluated, and sperm 
morphology was assessed using transmission electron microscopy and 
quantitatively elaborated. In the smoker and nonsmoker varicocele-associated 
cases, sperm motility and the results from transmission electron microscopy 
analysis were significantly impaired compared with controls. However, a non 
significant difference was detected when the semen parameters were 
compared. Subsequently, the patients were divided into 4 groups: mild (≥1 but 
≤10 cigarettes/d), moderate (>10 but <20 cigarettes/d), and heavy (≥20 
cigarettes/d) smokers and a group of randomly chosen nonsmoker patients with 
varicocele. The sperm motility, sperm concentration, and fertility index 
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decreased and the percentage of sperm pathologic features increased as the 
number of cigarettes smoked daily increased. 
 
The effect of smoking cigarette or shisha tobacco on semen parameters in 100 
men with subfertility was investigated (Hussein et al., 2011). There were 50 
smokers with mean age of 37.1±8.3 years and 50 non-smokers with a mean 
age of 39.5±9.0 years. When compared with non-smokers, the smokers had a 
significantly higher mean percentage of abnormal sperm forms (92.3% vs 
89.4%) (P<0.01), a significantly lower mean sperm count (20.6 M/mL vs 44.9 
M/mL), a significantly lower mean semen volume (2.01 mL vs 2.52 mL), and a 
significantly lower mean percentage of sperm motility (25.7 vs 37.9) (all with 
P<0.01). There were no statistically significant differences in semen parameters 
between men smoking cigarettes or shisha. There were statistically significant 
negative correlations between smoking index and the percentage of sperm 
motility (r=-0.38; P=0.006) and between smoking duration and the percentage 
of sperm motility (r=-0.32; P=0.026). There was also a marginally significant 
positive correlation between smoking index and the percentage of abnormal 
















Materials and Methods 
 
3.1 Study design 
The present study is a case control design. 
 
3.2 Target population 
The target population is smokers and non smokers men aged 20-50 years old 
from Gaza Governorate, Gaza Strip. 
 
3.3. Sampling and sample size 
Samples were collected from married men who visiting central laboratories such 
as Shaker and Balsam laboratories in Gaza Governorate and seeking for 
semen analysis. Samples were defined as non probability accidental samples. 
Men were divided into smoker and nonsmoker groups. The sample size 
calculations were based on the formula for case-control studies. EPI-INFO 
statistical package version 3.5.1 was used with 95% CI, 80% power and 50% 
proportion as conservative and OR >2. The sample size in case of 1:1 ratio of 
smoker non smoker (control) was found to be 51:51. For a no-response 
expectation, the sample size was increased to 54 smokers and was recruited 
from Gaza central laboratories. The controls were consisted of 54 nonsmokers. 
Case and control men were matched for age.  
 
3.4 Exclusion criteria 
Men with known causes of infertility, using contraceptive methods, newly 






3.5 Limitation of the study 
Place of the study was changed from Nuseirat area to Gaza governorate due to 
deficiency of samples.  
 
3.6 Ethical considerations  
The necessary approval to conduct this study was obtained from Helsinki 
committee in Gaza Strip (Annex 1). Helsinki committee is an authorized 
professional body for giving permission to researchers to conduct their studies 
with ethical concern in the area. The participants were given a full explanation 
about the purpose of the study and assurance about the confidentiality of the 
information and that the participation is optional.   
 
3.7 Data collection 
3.7.1 Questionnaire interview 
A face to face interview was used for filling in the questionnaire which is 
designated for matching the study need. The questionnaire (Annex 2) was 
based on Centers for Disease control and Prevention smoking questionnaire 
with some modification (Centers for Disease control and Prevention, CDC, 
2009). During the study the interviewer explained to the patients any of the 
confused questions that may be not clear to them. Most questions were the 
yes/no questions, which offer a dichotomous choice (Backstrom and Hursh-
César, 1981). The questionnaire was validated by four experts in the fields of 
epidemiology, public health, and environment. The  questionnaire was piloted 
with 10 patients, and with few modification as necessary to improve reliability. 
The questionnaire included questions on the personal data (age, having 
children, education and employment), medical history (Testes trauma and 
surgery, previous semen and hormone analyses) and smoking data (number of 







3.7.2 Semen collection and analysis 
Semen samples were collected from smokers and non smokers by 
masturbation in sterile polypropylene containers after sexual abstinence of 35 
days. Semen volume was measured. Routine semen analysis was carried out 
by light microscopy. The concentration, motility and morphology of spermatozoa 
were assessed according to WHO criteria (WHO, 1992).  
 
3.7.3 Blood sampling and processing  
Venous blood sample (5 ml) was drawn by a well trained medical technologist 
into vacutainer tubes from smokers and nonsmokers. Blood left for a while 
without anticoagulant to allow blood to clot. Then serum samples were obtained 
by centrifugation at room temperature at 3000 rpm/10 minutes for hormonal 
analysis. 
 
3.7.4 Hormonal analysis 
3.7.4.1 Testosterone hormone assay 
Testosterone hormone level was determined according to the method of Tiez, 
1986 using ELISA TECO kit for testosterone. 
 
Principle of the assay 
The testosterone ELISA Kit is a solid phase enzyme-linked immunosorbent 
assay (ELISA), based on the principle of competitive binding. The microtiter 
wells are coated with an antibody directed towards an unique antigenic site on 
the testosterone molecule. Endogenous testosterone of a patient sample 
competes with a testosterone horseradish peroxidase conjugate for binding to 
the coated antibody. After incubation the unbound conjugate is washed off. The 
amount of bound peroxidase conjugate is reverse proportional to the 
concentration of testosterone in the sample. After addition of the substrate 
solution, the intensity of colour developed is reverse proportional to the 







1. Microtiter wells, 12x8 (break apart) strips, 96 wells coated with mouse 
monoclonal anti-testosterone antibody 
2.  Standard (Standard 0-6), 7 vials, 1 ml, ready to use concentrations: 0 - 
0.2 - 0.5  1  2  6 - 16 ng/ml Conversion: 1 ng/ml = 3.467 nmol/l 
3. Enzyme conjugate, 1 vial, 25 ml, ready to use testosterone conjugated to 
horseradish peroxidase 
4. Substrate solution, 1 vial, 25 ml,  
5. Stop solution, 1 vial, 14 ml, ready to use contains 0.5M H2SO4. 
6.  Wash solution, 1 vial, 30 ml (40X concentrated) 




All samples and reagents were allowed to reach room temperature (~25°C). 
Reagents mixed by gentle inversion before use. Standards, controls and 
samples assayed in duplicate. 
1. Microtitration strip was marked to be used. 
2. Twenty-five µL of the standards, controls and samples were added into 
each appropriate well. 
3. Two hundred µL of conjugate reagent were added into each well using 
a precision pipette. 
4. The wells were mixed for 10 seconds.  
5. The wells were incubated for 60 minute at room temperature (~25°C). 
6. Each well was aspirated and washed 3 times by adding 400 µL of 
working wash solution. 
7. Two hundred µL of substrate solution were added into each well using a 
precision pipette and gently mixed for 10 seconds. 
8. The wells were incubated in the dark for 15 minute at room temperature 
(~25°C).  
9. One hundred µL of stop solution were added into each well using a 
precision pipette and mixed for 10-20 seconds. 
10. The absorbances of the solution in each well were read at 450 nm. 
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Calculation of results 
The absorbance for each standard, control, or samples were obtained, and then 
the stander curve prepared by plotting the absorbance readings for each of the 
standards along the Y-axis versus standard concentrations in ng/mL along the 
X-axis, the mean absorbance values for each sample were determined the 





                    Figure 3.1. Standard curve for testosterone hormone [ 
 
 
Normal reference values of testosterone for adult male 
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3.7.4.2 Luteinizing hormone (LH) assay 
Luteinizing hormone level was determined according to (Lenton et al., 1982) 
method using ELISA TECO kit for LH. 
 
Principle of the assay 
The essential reagents required for an immunoenzymometric assay include 
excess amount of antibodies (both enzyme conjugated and immobilized) with 
high affinity, high specificity and contain different epitopes with distinct 
recognition and native antigen. In this assay procedure, the immobilization 
takes place at the surface of a microplate well through the interaction of 
streptavidin coated on the well and exogenously added biotinylated monoclonal 
anti-LH antibody. Upon mixing, a reaction results between the native antigen 
contained in serum, the monoclonal biotinylated antibody and the enzyme-
labeled antibody, without competition or steric hindrance, to form a soluble 
sandwich complex. Simultaneously, the complex is deposited to the well 
through the high affinity reaction of streptavidin and biotinylated antibody. After 
equilibrium is attained, the antibody-bound fraction is separated from unbound 
antigen by decantation or aspiration. The enzyme activity in the antibody-bound 
fraction is directly proportional to the native antigen concentration. By utilizing 
several different serum references of known antigen value, a dose response 
curve can be generated from which the antigen concentration of an unknown 
can be ascertained.  
 
Kit components  
One stripholder containing 96 microtitration wells coated with streptavidin, six 
LH reference standards with concentrations of approximately (0, 5.0, 25, 50, 
100 and 200 mIU/mL). Enzyme conjugate, TMB chromogen solution, stop 
solution and wash solution concentrate. 
 
Assay procedure  
All samples and reagents were allowed to reach room temperature (~25°C). 




and samples assayed in duplicate. 
1. Microtitration strip was marked to be used. 
2. Fifty µL of the standards, controls and samples were added into each 
appropriate well. 
3. One hundred µL of conjugate reagent were added into each well using 
a precision pipette and then mixed for 30 seconds. 
4. The wells were incubated for 60 minutes at room temperature (~25°C). 
5. Each well was aspirated and washed 3 times by added 300 µL of 
working wash solution. 
6. One hundred µL of TMB reagent were added into each well and gently 
mixed for 10 seconds. 
7. The wells were incubated in the dark for 15 minutes at room temperature 
(~25°C) without shaking. 
8. Fifty µL of stop solution were added into each well and gently mixed for 
10-20 second. 
9. The absorbance for each well was read at 450 nm.  
 
Calculation of results 
The absorbance for each standard, control, or samples were obtained, and then 
the stander curve prepared by plotted the absorbance readings for each of the 
standards along the Y-axis versus standard concentrations in mIU/mL along the 
X-axis, the mean absorbance values for each sample were determined the 
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Figure 3.2. Luteinizing hormone standard curve3 
 
 
Normal reference values of LH for adult male 






































3.7.4.3 Follicle stimulating hormone (FSH) assay 
Follicle stimulating hormone level was determined according to (Vitt et al., 1998) 
method, using ELISA TECO kit for FSH. 
 
Principle of the assay, kit components, assay procedure and calculation 












      




                   Figure 3.3. Follicle stimulating hormone standard curve 
 
Normal reference value of FSH for adult female 
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3.7.4.4 Prolactin hormone assay 
Prolactin hormone level was determined according to (Tietz, 1995) method 
using ELISA TECO kit for prolactin. 
 
Principle of the assay 
The essential reagents required for sandwich enzyme-linked immunoassay 
include excess amount of antibodies (both enzyme conjugated and 
immobilized) with high affinity, high specificity and contain different epitopes 
with distinct recognition and native antigen. In this assay, a certain amount of 
prolactin hormone calibrator, patient specimen or control is first added to a 
microplate well. Biotinylated monoclonal and enzyme labeled antibodies 
(directed against distinct and different epitopes of PRL) are added and the 
reactants mixed. Immobilization of the tagged PRL occurs through the 
interaction of streptavidin coated on the well and the added biotinylated 
monoclonal anti-PRL antibody. Upon mixing a reaction results between the 
native antigen contained in serum, the monoclonal biotinylated antibody and the 
enzyme-labeled antibody, without competition or steric hindrance, to from a 
soluble sandwich complex bound to the surface of  microplate through the 
streptavidin-biotin system. After equilibrium is attained the antibody-bound 
fraction is separated from unbound antigen by decantation or aspiration. The 
enzyme activity in the antibody-bound fraction is directly proportional to the 
native antigen concentration. By several different serum references of known 
antigen value, a dose response curve can be generated from which the antigen 
concentration of an unknown can be ascertained.  
 
Kit components  
One stripholder containing 96 microtitration wells coated with streptavidin, six 
prolactin reference standards with concentrations of approximately (0, 5.0, 10, 
25, 50 and 100 ng/mL). Enzyme conjugate, TMB chromogen solution, stop 






Assay procedure  
All samples and reagents were allowed to reach at room temperature (~25°C). 
Reagents mixed by gentle inversion before use. Standards, controls and 
samples assayed in duplicate. 
1. Microtitration strip was marked to be used. 
2. Twenty-five µL of the standards, controls and samples were added into 
each appropriate well. 
3. One hundred µL of conjugate reagent were added into each well using 
a precision pipette. 
4. The wells were mixed for 30 seconds.  
5. The wells were incubated for 60 minute at room temperature (~25°C). 
6. Each well was aspirated and washed 3 times by added 300 µL of 
working wash solution. 
7. One hundred µL of TMB reagent were added into each well using a 
precision pipette and gently mixed for 10 seconds. 
8. The wells were incubated in the dark for 15 minute at room temperature 
(~25°C).  
9. Fifty µL of stop solution were added into each well using a precision 
pipette and mixed for 10-20 seconds. 
10.  The absorbances of the solution in each well were read at 450 nm. 
 
Calculation of results 
The absorbance for each standard, control, or samples were obtained, and then 
the standard curve prepared by plotted the absorbance readings for each of the 
standards along the Y-axis versus standard concentrations in ng/mL along the 
X-axis, The mean absorbance values for each sample were determined the 
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Figure 3. 3 
 
Figure 3.4. Prolactin hormone standard curve. 
 
Normal reference values of prolactin for adult male 





























3.8 Statistical analysis  
Data were computer analyzed using SPSS/ PC (Statistical Package for the 
Social Science Inc. Chicago, Illinois USA, version 18.0) statistical package. 
Simple distribution of the study variables and the cross tabulation were 
applied. Chi-square (2) was used to identify the significance of the relations, 
associations, and interactions among various variables. Yatess continuity 
correction test,  2 (corrected), was used when not more than 20% of the cells 
had an expected frequency of less than five and when the expected numbers 
were small. The independent sample t-test procedure was used to compare 
means of quantitative variables by the separated cases into two qualitative 
groups such as the relationship between patients and controls hormones. The 
one-way ANOVA test was applied.  
 
The results in all the above mentioned procedures were accepted as statistical 
significant when the p-value was less than 5% (p<0.05). 
 
Range as minimum and maximum values were used.  
 
The percentage difference was calculated according to the formula: 
Percentage difference equals the absolute value of the change in value, divided 
by the average of the 2 numbers, all multiplied by 100. 
Percent difference = ( | (V1  V2) | / (( V1+ V2)/2) ) X 100  
 
















4.1 Personal characters of the study population  
Table 4.1 illustrates the personal data of the study population. Age classification 
showed that 28 (51.9%) controls and 31 (57.4%) cases were 20-30 years old. 
Age group 31-40 years comprised 20 (37.0%) controls and 18 (33.3%) cases. 
Controls and cases aged 41-50 years old were 6 (11.1%) and 5 (9.3%), 
respectively. The difference between controls and cases in term of age 
distribution was not significant (2=0.349, P=0.840). The mean ages of controls 
and cases were 33.5±7.6 and 32.7±6.3 years old with ranges of 22-50 and 24-
50 years, respectively. The independent sample t-test also showed no 
significant difference between mean ages of controls and cases (t=0.378, 
P=0.707). Forty four (81.5%) controls compared to 20 (37.0%) cases having 
children (Figure 4.1), and the difference between controls and cases was 
significant (2=22.091, P=0.000) indicating that smoking is a risk factor of male 
infertility. Analysis of the educational status of the study population showed that 
24 (44.4%) controls and 26 (48.1%) cases had a university degree, 20 (37.0%) 
and 14 (25.9 %) finished secondary school, 8 (14.8%) and 10 (18.5%) had 
finished preparatory school and 2 (3.7%), 4 (7.4%) had passed primary school. 
The difference between various education levels of controls and cases was not 
significant (2 corrected=0.978, P=0.807). It is worth mentioning that non of 
controls and cases were illiterate. The employed controls and cases were 
27(50.0%) and 22 (40.7%) whereas 27 (50.0%) controls and 32 (59.3%) cases 

































































































































Table 4. 1 
*p-value of 2 (corrected) test 
 
                                                                                                                             
                                                                








 81.5%                                                                    63.0% 












4.2 Medical history of the study population 
The medical history of the study population is presented in Table 4.2. None of 
the controls 0 (0.0%) had trauma compared to 4 (7.4 %) cases. The difference 
between the two groups was not significant (2 corrected=2.337, P=0.126). 
Regarding testes surgery, 6 (11.1%) controls had surgery in testes compared to 
18 (33.3%) cases. The difference was significant (2 =7.714, P=0.005). Controls 
who had semen and hormone analyses were 16 (29.9%) and 5 (9.3%) 
compared to 48 (88.9%) and 45 (83.3%) cases (2 =39.273, P=0.000 and 2 
=59.586, P=0.000).  
 






























































































Table 4. 2 
*p-value of 2 (corrected) test 
 
 
4.3 Smoking and fertility 
4.3.1 Passive smoking among the study population 
Table 4.3 demonstrates passive smoking among the study population. A total of 
20 (37.0%) controls and 52 (96.3%) cases had been exposed to passive 
smoking compared to 34 (63.0%) and 2 ( 3.7%) who had not. The difference 






































Table 4. 3 
*p-value of 2 (corrected) test 
 
 
4.3.2 Type of smoking and frequency/day among cases 
Type of smoking and frequency/day among cases are summarized in table 4.4. 
Forty six (85.2%) cases were cigarette smokers and 8 (14.8%) were nergella 
smokers. The number of cases who smoked cigarette <10, 10-20 and >20 
cigarettes/day were 10 (21.7%), 16 (34.8%) and 20 (43.5%), respectively 
whereas those smoked nergella one time, 2 times and >2 times/day were 4 
(50.0%), 2 (25.0%) and 2 (25.0%), respectively.   
 
 
























































4.3.3 Duration of smoking among cases  
Duration of smoking among cases is pointed out in Table 4.5. The number of 
cases who smoked for <5, 5-15 and >15 years were 14 (25.9%), 28 (51.9%)  
and 12 (22.2%), respectively. 
 

















4.3.3.1 Duration of smoking in relation to have children among cases  
Table 4.6 and Figure 4.2 provide duration of smoking in relation to have children 
among cases. Ten (18.5%), 6 (11.1%) and 4 (7.4%) cases  who have children 
smoked for <5, 5-15 and >15 years, respectively compared to 4 (7.4%), 18 
(33.3%) and 12 (22.2%) who have no children (2 corrected=7.267, P=0.026).      
  




Smoking duration (year) 






             <5 
            5-15 
            >15 
10 (18.5) 


































Figure 4.2 Duration of smoking in relation to have children among cases  
 
4.3.4 Negative impact of smoking on sexual desire and erection  
among cases 
Negative impact of smoking on sexual desire and erection among cases is 
given in Table 4.7. The number of cases reported negative impact of smoking 
on sexual desire was 16 (29.6%) where as 8 (14.8%) cases mentioned that 
smoking has negative impact on erection. 
 




Negative impact of smoking on 
sexual desire and erection of cases No. % 
             Sexual desire 
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             Erection 
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4.4 Semen parameters of the study population  
Table 4.8 summarized semen parameters of the study population. The means 
of sample volume, total count and active sperm were significantly decreased in 
cases compared to controls with percentage difference of 41.2%, 103.5% and 
65.1%, respectively (2.7±1.3, 16.7±16.1 and 22.0±16.3 v 4.1±1.9, 52.6±14.6 
and 43.3 ± 11.2, with P=0.004, P=0.000 and P=0.000 respectively).  In contrast, 
the mean of abnormalities and dead sperms were markedly increased in cases 
compared to controls showing percentage differences of 71.2% and 47.1%, 
respectively (23.0±9.9 and 57.9±16.2 v 10.9±6.0 and 35.8±10.2, respectively, 
P=0.000). On the other hand, no significant change was found in sluggish 
sperm levels between cases and controls (21.6±9.0 v 21.0±3.5, % 
difference=2.8%, P=0.754). 
 
Table 4.8 Semen parameters of the study population 














41.2 2.984 0.004 
 





































47.1 5.948 0.000 
Table 4. 4 
All values are expressed as mean±SD 







4.5 Hormonal profile of the study population  
Hormonal profile of the study population is illustrated in Table 4.9. The mean 
levels of testosterone, LH, FSH and prolactin in cases showed no significant 
decrease compared to controls with percentage differences of 16.8%, 16.7%, 
9.5% and 10.6%, respectively (4.9±2.9, 4.4±1.7, 5.0±2.4 and 9.8±3.1 v 5.8±2.0, 
5.2±1.0, 5.5±1.1 and 10.9±2.1, with P=0.189, P=0.060, P=0.324 and P=0.274, 
respectively).  
 






































10.6 1.175 0.274 
 
Table 4. 5 
*LH: Luteinizing hormone, **FSH: Follicle stimulating hormone 
All values are expressed as mean±SD 













4.6 Number of cigarette/day in relation to semen 
parameters and hormonal profile of the cases  
 
4.6.1 Number of cigarette/day in relation to semen parameters 
of the cases  
Table 4.10 shows the number of cigarettes/day in relation to semen parameters 
of the cases. There is a successive significant decrease in the mean number of 
active sperms with increasing number of smoked cigarettes/day showing values 
of 40.0±18.7, 20.6 ±10.8 and 16.8±13.3 million/ml with <10, 10-20 and >20 
cigarette/day, respectively, P=0.018  (Figure 4.3). However, the mean dead 
sperms was significantly increased showing values of 44.2±18.5, 54.1±8.7 and 
66.4±15.7 million/ml with <10, 10-20 and >20 cigarettes/day, respectively, 
P=0.028 (Figure 4.4). In general, sperm abnormalities were increased whereas 
sample volume, total count and sluggish sperms were decreased with the 
increased number of cigarettes/day. However, such changes were not 
significant (P>0.05).  
  
Table 4.10 Number of smoked cigarettes/day in relation to semen parameters of 
the cases 
No. of smoked cigarettes/day Semen parameter 
<10 10-20 >20 F P-value 
Sample volume (ml) 2.9±1.2 3.3±1.7 2.3±1.2 1.408 0.268 
Total count (million/ml) 20.9±10.7 15.6±12.8 12.0±6.2 1.348 0.282 
Abnormalities  19.6±5.5 29.0±13.7 21.7±8.6 1.588 0.230 
Active (million/ml) 40.0±18.7 20.6±10.8 16.8±13.3 4.914 0.018 
Sluggish (million/ml) 23.8±12.1 25.3±4.8 17.8±6.4 3.190 0.073 
Dead (million/ml) 44.2±18.5 54.1±8.7 66.4±15.7 4.284 0.028 
Table 4. 6 
All values are expressed as mean±SD 






















Figure 4.3 Number of smoked cigarette/day in relation to mean number of active 













Figure 4.4 Number of smoked cigarette/day in relation to mean number of dead 
sperms (million/ml).  
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4.6.2 Number of cigarettes/day in relation to hormonal profile 
of the cases  
The number of cigarettes/day in relation to hormonal profile of the cases is 
presented in Table 4.11. Testosterone and prolactin exhibited no significant 
increase with increasing the number of smoked cigarette/day showing 
maximum values of 5.7±4.3 and 10.3±2.9 with >20 cigarette/day (P=0.471 and 
P=0.373, respectively). In contrast, LH and FSH were gradually decreased 
registering maximum decreases of 3.4±1.4 and 4.7±2.7 ( P=0.621 and P=0.875, 
respectively).  
 
Table 4.11 Number of cigarettes/day in relation to hormonal profile of the cases 
No. of cigarette/day Hormone 
<10 10-20 >20 F P-value 
Testosterone (ng/ml) 4.2±1.1 4.4±1.3 5.7±4.3 0.782 0.471 
LH (mIU/ml)* 4.5±2.3 4.5±2.6 3.4±1.4 0.493 0.621 
FSH (mIU/ml)** 5.4±2.3 4.8±2.8 4.7±2.7 0.135 0.875 
Prolactin (ng/ml) 5.7±2.1 9.8±1.9 10.3±2.9 1.208 0.373 
Table 4. 7 
*LH: Luteinizing hormone, **FSH: Follicle stimulating hormone 
All values are expressed as mean±SD 
P>0.05: non significant 
 
 
4.7 Duration of smoking in relation to semen 
parameters and hormonal profile among cases 
 
4.7.1 Duration of cigarette smoking in relation to semen 
parameters of the cases 
Table 4.12 illustrates duration of cigarette smoking in relation to semen 
parameters of the cases. There is an obvious significant decrease in the mean 
total count and active sperms with duration of smoking showing maximum 
decrease of 4.8±3.3 and 7.2±5.1 million/ml with >15 of smoking, P=0.021 and 
P=0.023, respectively (Figure 4.5 and Figure 4.6). In contrast, dead sperms 
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were significantly increased showing mean numbers of 49.1±14.7, 55.2±13.9 
and 74.5±11.8 million/ml with <5, 5-15 and >15 years of smoking, respectively, 
P=0.007 (Figure 4.7). In general, sperm abnormalities were increased whereas 
sample volume and sluggish sperms were decreased with the increase smoking 
duration. However, such changes were not significant (P>0.05).  
 
Table 4.12 Duration of cigarette smoking in relation to semen parameters of the   
cases 
Duration of cigarette smoking (Year) Semen parameter 
<5 5-15 >15 F P-value 
Sample volume (ml) 3.0±1.1 2.8±1.6 2.1±0.7 0.726 0.494 
Total count (million/ml) 28.7±25.9 15.8±7.8 4.8±3.3 4.584 0.021 
Abnormalities  18.5±4.2 24.5±11.0 24.4±11.4 0.824 0.452 
Active (million/ml) 30.1±20.5 24.3±13.6 7.2±5.1 4.419 0.023 
Sluggish (million/ml) 20.7±8.0 23.4±8.2 18.3±12.1 0.680 0.516 
Dead (million/ml) 49.1±14.7 55.2±13.9 74.5±11.8 6.114 0.007 
Table 4. 8 
All values are expressed as mean±SD 














Figure 4.5. Duration of cigarette smoking in relation to total count of sperms 
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Figure 4.6. Duration of cigarette smoking in relation to active sperm count 
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4.7.2 Duration of cigarette smoking in relation to hormonal 
profile among cases 
The duration of cigarette smoking in relation to hormonal profile among cases 
 is shown in Table 4.13. Testosterone exhibited no significant decrease with 
increasing smoking duration showing maximum decrease of 4.3±1.2 with >15 
years of smoking (P=0.876). In contrast, LH, FSH and prolactin showed no 
significant increase with maximum increases of 5.4±2.5, 6.0±2.3 and 10.0±3.3 
with >15 years of smoking (P=0.280, P=0.313 and P=0.987, respectively).  
 
Table 4.13 Duration of smoking in relation to hormonal profile of the cases 
Duration of smoking (Year) Hormone 
<5 5-15 >15 F P-value 
Testosterone (ng/ml) 5.0±1.9 5.0±3.8 4.3±1.2 0.133 0.876 
LH (mIU/ml)* 3.8±1.6 3.8±1.8 5.4±2.5 1.362 0.280 
FSH (mIU/ml)** 4.0±1.8 5.1±2.6 6.0±2.3 1.220 0.313 
Prolactin (ng/ml) 9.5±4.5 9.7±3.3 10.0±3.3 0.013 0.987 
Table 4. 9 
*LH: Luteinizing hormone, **FSH: Follicle stimulating hormone 
All values are expressed as mean±SD 


















It is believed that wrongly in the Middle East both virility and fertility are typically 
tied to manhood. Fertility is the natural capability to produce offspring. Total 
fertility rate (TFR) - the total number of children a woman would bear during her 
lifetime if she were to experience the prevailing age-specific fertility rates of 
women. TFR equals the sum for all age groups of 5 times each Age-specific 
fertility rate (Garrett, 2001). Patterns of male fertility vary greatly among regions 
and even within regions. A combination of social habits e.g. cigarette smoking, 
environmental conditions, and genetics is suspected to contribute to this 
variation (Kidd et al., 2001). In Gaza strip there are under-reporting of male 
fertility or even no study link between smoking and fertility in men. Therefore, 
the present study is the first to evaluate the risk of cigarette smoking on male 
fertility in Gaza Governorate, Gaza Strip.  
 
5.1 Personal characteristics and medical history of the 
study population  
The present study was case control design comprising 54 controls (non 
smokers) and 54 cases (smokers). The mean ages of controls and cases were 
33.5±7.6 and 32.7±6.3 years old, respectively. Age distribution in our study was 
an independent factor to affect male fertility. Similar result was reported 
(Kumtepe et al., 2003). The number of cases who had children was significantly 
lower than controls indicating that smoking could be a risk factor of male fertility. 
However education and employment were not found to be associated with male 
fertility. Concerning medical history of the study population, the number of 
cases who had testes surgery was higher than controls implying that testes 
surgery may have some extent of a negative impact on male fertility which 
seems to be  exacerbated by smoking. This finding was in agreement with that 
reported by Collodel et al. (2009) who found that smoking cigarettes increases 
the effect of varicocele on sperm morphology. Regarding previous semen and 
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hormone analyses, the number of cases who seeking such analyses was higher 
than controls. Therefore, in my opinion cases had lower rate of fertility which 
may be more likely link to smoking.  
 
5.2 smoking and fertility 
5.2.1 Passive smoking among the study population 
The number of cases who exposed to passive smoking was significantly higher 
than controls indicating that passive smoking may be associated with male 
fertility. This finding coincides with that mentioned by American Society for 
Reproductive Medicine (2003) which reported that  the harmful effect of passive 
smoke on the fertility of female partners and the evidence that smoking 
adversely affects sperm quality suggest that smoking in men should be 
regarded to as an infertility risk factor. It has been shown that passive exposure 
to environmental tobacco smoke resulted in measurable seminal nicotine and 
cotinine levels correlated with the degree of reported exposure (Pacifici R. et al., 
1995). It is accepted that nicotine and its metabolite cotinine may lead to poor 
semen function and resultant infertility (Arabi and Shareghi, 2005). 
 
5.2.2 Type of smoking, frequency/day, duration and negative 
impact  on sexual desire and erection 
The present result showed that the majority of cases were cigarette smokers 
and around half of them smoked more than 20 cigarette/day. In addition, more 
than half of the cases smoked for 5-15 years. These circumstances may put 
them at a high risk of male infertility. This view was supported by the finding that 
the longer duration of smoking, the less number of cases having children. 
These results are in agreement with that found by Collodel et al. (2009) who 
demonstrated that the sperm motility, sperm concentration, and fertility index 
decreased and the percentage of sperm pathologic features increased as the 
number of cigarettes smoked daily increased. According to Centers for Disease 
Control and Prevention (2009), sperm from chronic smokers were 75 % less 
fertile than sperm from nonsmokers. Men who were lighter smokers suffered 
less severe decreases in fertility. In addition, significant negative correlation was 
obtained between smoking duration and percentage of sperm motility (Hussein 
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et al., 2011). Concerning negative impact of smoking, data presented here 
showed that smoking affect sexual desire and erection in about quarter of 
cases. Difficulties in getting pregnant may be from the effects of the nasty 
chemicals in cigarette smoke that affect the man's sperm and libido (Quitters 
Guide, 2008). In addition, it was reported that cigarette smoking raised risk of 
erectile dysfunction (Miron et al., 2002 and He et al., 2007).  
 
5.3 Semen parameters of the study population  
The mean sample volume, total count and active sperm were significantly 
decreased whereas the mean levels of abnormalities and dead sperm were 
markedly increased in cases compared to controls. These findings on semen 
quality are in agreement with that documented by Wong et al., (2000), Kunzel et 
al., (2007) and Hussein et al., (2011). Nicotine in tobacco and its metabolite 
cotinine may lead to poor semen function and resultant infertility (Arabi and 
Shareghi, 2005). Cigarette smoke contains also carbon monoxide which may 
affect male reproduction via direct effect on the testicular function and 
spermatogenesis (Hanrahan et al., 1996). 
 
When semen parameters were related to the number of smoked cigarettes/day 
and duration of smoking, the present results showed a significant decrease in 
the mean number of active sperms whereas the mean of dead sperms was 
significantly increased with increasing number of smoked cigarettes/day and 
smoking duration. In addition, total sperm count was significantly decreased 
only with increasing smoking duration. However, the other semen parameters 
were not significantly affected. Such results were in concurrent with that 
addressed by Zhang et al., (2000) who found significant negative correlation 
between sperm density, viability and forward progression with the amount  and 
duration of cigarette smoking. Additionally, Collodel et al. (2009)  pointed out 
that the sperm motility, sperm concentration, and fertility index decreased and 
the percentage of sperm pathologic features increased as the number of 





5.4 Hormonal profile of the study population  
The mean levels of testosterone, LH , FSH and prolactin in cases showed no 
significant decrease compared to controls. Similar results were obtained by 
Attia et al. (1989) and English et al. (2001). However, our findings were in 
contradiction with that mentioned by Field et al. (1994) who reported that 
cigarette smoking had increased serum levels of testosterone by 9% and with 
that of Ramlau-Hansen et al. (2007) who found a positive doseresponse 
relationship between smoking and testosterone, LH and the LH/free 
testosterone ratios. This contradiction was frequently encountered in literature 
among different population and may be related to different life style and 
environment. Also, the number of smoked cigarettes/day and duration of 
smoking had no significant effect on hormonal profile. In conclusion, cigarette 
smoking affects fertility by its main negative impact on semen parameters rather 






















Conclusions and Recommendations 
 
6.1 Conclusions 
* The mean ages of controls and cases were 33.5±7.6 and 32.7±6.3 years, 
respectively.  
 
* The number of cases who had children was significantly lower than controls. 
 
* The number of cases who had testes surgery, previous semen and hormone 
analysis was higher than controls. 
 
* The number of cases who exposed to passive smoking was significantly 
higher than controls. 
 
* The majority of cases were cigarette smokers and around half of them smoked 
more than 20 cigarettes/day. In addition, more than half of the cases smoked for 
5-15 years. The longer duration of smoking, the less number of cases having 
children.  
 
* Smoking  had negative impact on sexual desire and erection in about quarter 
of cases. 
 
* The means of sample volume, total count and active sperm were significantly 
decreased whereas the means of abnormalities and dead sperm were markedly 
increased in cases compared to controls. 
 
* Relation of semen parameters to the number of smoked cigarettes/day and 
duration of smoking showed a significant decrease in the number of active 
sperms whereas dead sperms was significantly increased with increasing 
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number of smoked cigarettes/day and smoking duration. In addition, total sperm 
count was significantly decreased only with increasing smoking duration. 
 
* The mean levels of testosterone, LH , FSH and prolactin in cases showed no 
significant decrease compared to controls. Also, the number of smoked 
cigarettes/day and duration of smoking had no significant effect on hormonal 
profile. 
 
* Finally, cigarette smoking affects fertility by its main negative impact on semen 
























* Health education programs should be launched on the importance of quitting 
smoking and its positive impact on male fertility in terms of improving semen 
parameters, sexual desire and erection.  
 
* Risk of cigarette smoking on male fertility must be explained to couples 
interested in getting pregnant in vitro via IVF "In Vitro Fertilization" to optimize 
the success rate.  
 
* Exposure to passive smoking must be avoidable. 
 
























Alaa Hussein, Ayman AlGadaa, Mohamed ElFaras, Medhat ElFiky Wed,. 12 
January 2011. Effect of Tobacco Smoking on Semen Quality in Men With 
Subfertility. King Fahd Specialized Hospital, IVF Center, PO Box 2290, Buridah, 
Qassium Region, Kingdom of Saudi Arabia Urotoday IntJ. 4(1):art11. 
doi:10.3834/uij.1944-5784.2011.02.11 
 
Andersen AN, Schioler V, Hertz J, Bennet P. 1982. Effect of Metoclopramide-
Induced Hyperprolactinaemia on the Gonadotrophic Response to Oestradiol 
and LRH. Acta Endocrinol;100:19. 
 
Arabi M, Shareghi B. 2005. Anti-fertility effect of nicotine. Zhonghua Nan Ke  
Xue, 11(5) : 323-330.    
 
Attia AM, el-Dakhly MR, Halawa FA, Ragab NF, Mossa MM.1989. Cigarette 
smoking and male reproduction. Andrology and Dermatology Department, 
Monofeya University, Cairo, Egypt, 23(1):45-9. 
 
Backstrom, C.H., and Hursh-César, G. 1981. Survey research (New York, 
Wiley). 
 
Baltz, J.M., Williams, P.O., and Cone, R.A. 1990. Dense fibers protect 
mammalian sperm against damage. Biol Reprod 43, 485-491. 
 
Beastall GH, et al. 1987. Assays for Follicle Stimulating Hormone and 
Luteinizing Hormone: Guidelines for the Provision of a Clinical Biochemistry 
Service. Ann Clin Biochem;24:24662. 
 
Bermudez, D., Escalier, D., Gallo, J.M., Viellefond, A., Rius, F., Perez 
deVargas, I., and Schrevel, J. 1994. Proacrosin as a marker of meiotic and 
53 
 
post-meiotic germ cell differentiation: quantitative assessment of human 
spermatogenesis with a monoclonal antibody. J Reprod Fertil 100, 567-575. 
 
Bernstein D. Tyler JPP. Driscoll GL. 1995. A comparison of WHO and 
Tygerberg strict criteria for assessing human spermatozoal morphology 
Australian Journal of Medical Science; 16(3): 115-117.  
 
Boepple, P.A., Hayes, F.J., Dwyer, A.A., Raivio, T., Lee, H., Crowley, W.F., and 
Pitteloud, N. 2008. Relative Roles of Inhibin B and Sex Steroids in the Negative 
Feedback Regulation of Follicle-Stimulating Hormone in Men across the Full 
Spectrum of Seminiferous Epithelium Function. The Journal of clinical 
endocrinology & metabolism 93, 1809. 
 
Bonnar J. Gynaecology and Obstetrics: 1973. The Hypothalamus and 
Reproductive Function. In: Scott RB and Walker RM, editors. The Medical 
Annual. Bristol (England): J Wright and Sons,;2518. 
 
Bowers CY, Friesen HG, Hwang P, Guyda HJ, Folkers K. 1971. Prolactin and 
Thyrotropin Release in Man by Synthetic Pyroglutamyl-histidyl-prolinamide. 
Biochem- Biophys Res Commun;45:103341. 
 
Catt KJ, Pierce JG. 1978. Gonadotropic Hormones of the Adenohypophysis. In: 
Yen SSC and Jaffe RB editors. Reproductive Endocrinology. Philadelphia: 
Saunders,;3462. 
 
Centers for Disease control and Prevention 2009. Office on Smoking and 
Health, National Center for Chronic Disease Prevention and Health  Promotion.  
 
Chia SE, Tay SK, Lim ST. 1998. What constitutes a normal seminal analysis? 
Semen parameters of 243 fertile men. 13(12):3394-8. 
 
Coelho C, Júlio C, Silva G, Neves A. 2009. Tobacco and male infertility: a     
retrospective study in infertile couples. 22(6):753-8. 
54 
 
Collodel G, Capitani S, Iacoponi F, Federico MG, Pascarelli NA, Moretti E. 
2009.  Retrospective assessment of potential negative synergistic effects of 
varicocele and tobacco use on ultrastructural sperm morphology. 74(4):794. 
 
Crowley WF Jr, Filicori M, Santoro NF. 1987. GnRH Secretion Across the 
Normal Menstrual Cycle. In: Crowley WF Jr and Hofler JG, editors. The  
Episodic Secretion of Hormones. New York: John Wiley and Sons,;21931. 
 
Daughaday WH. 1985. The Adenohypophysis. In: Wilson JD, Foster DW, 
editors. Williams Textbook of Endocrinology. Philadelphia: Saunders,;803. 
 
Demura R, Ono M, Demura H, Shizume K, Oouchi H. 1982. Prolactin Directly 
Inhibits Basal as Well as Gonadotropin-Stimulated Secretion of Progesterone 
and 17-Estradiol in the Human Ovary. J Clin Endocrinol Metab;54:124650. 
 
Dunn JF, Nisula BC and Rodbard D. 1981. Transport of steroid hormones: 
binding of 21 endogenous steroids to both testosterone-binding globulin and 
corticosteroid-binding globulin in human plasma. J. of Clinical Endocrinology  
and Metabolism;53:5868 
 
English KM, Pugh PJ, Parry H, Scutt NE, Channer KS, Jones TH. 2001. Effect 
of cigarette smoking on levels of bioavailable testosterone in healthy  men. 
100(6):661-5. 
 
Field, A. E., Colditz, G. A., Willett, W. C., Longcope, C. and McKinlay, J. B. 
1994. The relation of smoking, age, relative weight and dietary intake to serum 
adrenal steroids, sex hormones and sex hormone-binding globulin in middle-
aged men. J. Clin. Endocrinol. Metab 79, 1310±1316. 
 
Franchimont P. 1973. Human Gonadotropin Secretion in Male Subjects. In: 
James VHT, Serio M and Martini L, editors. The Endocrine Function of the 
Human Testis. New York: Academic Press,;43958. 
55 
 
Fr10\anks S, Nabarro JDN, Jacobs HS. 1977. Prevalence and Presentation of 
Hyperprolactinaemia in Patients with Functionless Pituitary Tumours. 
Lancet;i:78880. 
 
Frantz AG, Kleinberg DL, Noel GL. 1972. Studies on Prolactin in Man. Recent 
Prog Horm Res;28:52790. 
 
Frantz AG. 1978. Prolactin. N Engl J Med;298:201-7. 
 
Friesen H, Guyda H, Hwang P, 1972. Tyson JE, Barbeau A. Functional 
Evaluation of Prolactin Secretion: A Guide to Therapy. J Clin Invest;51:7069. 
 
Garrett, E. 2001. Family Size in England and Wales: Place, Class, and  
Demography. Cambridge, England. 
 
Griffin JE, Wilson JD. 1985. Disorders of the Testes and Male Reproductive 
Tract. In: Wilson JD, and Foster DW, editors. Williams Textbook of  
Endocrinology. Philadelphia: Saunders,;259311. 
 
Griswold, M. 1998. The central role of Sertoli cells in spermatogenesis. 
Seminars in cell & developmental biology, 9, 411-6. 
 
Hanrahan JP, Sherman CB, Bresnitzf EA, Emmons KM, Manion DM. 1996. 
Cigarette smoking and health. Am J Respir Crit Care Med, 153: 861-865. 
 
Haider, S. 2004. Cell biology of Leydig cells in the testis. International review of 
cytology, 181-241. 
 
Hayes, F.J., DeCruz, S., Seminara, S.B., Boepple, P.A., and Crowley, W.F.,  Jr. 
2001. Differential regulation of gonadotropin secretion by testosterone in the 
human male: absence of a negative feedback effect of testosterone on follicle-
stimulating hormone secretion. The Journal of clinical endocrinology and 
metabolism 86, 53-58. 
56 
 
Henkel, R., Stalf, T., Mertens, N., Miska, W., and Schill, W.B. 1994. Outer  
dense fibers of human spermatozoa: partial characterization and possible 
physiological functions. Int J Androl 17, 68-73. 
 
Hosseinzadeh colayer, G.A. Jorsarraee and E.Tahmasbpour Marzong. 2007.  
Cigarette Smoking and the Risk of Male Infertility. IssN 1028-8880. 
 
Irvine DS. Aitken RJ. 1994. Seminal fluid analysis and sperm function testing. 
Endocrinology & Metabolism Clinics of North America.;23(4):725-48. 
 
Irvine DS. 1995. Computer assisted semen analysis systems: Sperm motility 
assessment. Human Reproduction.;10(SUPPL. 1): 53-59.  
 
Jeffcoate SL. 1975. The Control of Testicular Function in the Adult. Clinics in 
Endocrinology and Metabolism;4:52143. 
 
Jin-Ping ZHANG, Qing-Yu MENG, Qiang WANG, Lei-Jia ZHANG, Yi-Long 
MAO, Zhuo-Xiang SUN. 2000. Effect of smoking on semen quality of infertile 
men in Shandong, Department of Histology/Embryology, Jining Medical 
College, Shandong 272113, China Affiliated Hospital, Jining Medical College, 
Shandong 272129, China 
 
Kauppila A, Leinonen P, Vihko R, Ylostalo P. 1982. Metoclopramide-Induced 
Hyperprolactinemia Impairs Ovarian Follicle Maturation and Corpus Luteum 
Function in Women. J Clin Endocrinol Metab;54:95560. 
 
Kidd SA, Eskenazi B, Wyrobek AJ February 2001. Effects of male age on 
semen quality and fertility: a review of the literature. Fertil. Steril. 75 (2): 237  
48.doi:10.1016/S0015-0282(00)01679-4. PMID 11172821.  
 
Kierszenbaum, A.L. 2002. Genomic imprinting and epigenetic reprogramming: 




Kretser, D.m. 2002. Endocrinology Of The Male Reproductive System 
(Dartmouth, MA, MDText.com). 
 
Krohmer, R.W. 2004. The reproductive system (Philadelphia, Chelsea House). 
 
Kumtepe, Y., Yakin, K., Kahraman, S., Sertyel, S., Vanlioglu, F., Cengiz, S. and 
'˶nmez, E. 2003. "Male age is not an independent factor to affect the outcome 
of assisted reproductive techniques." International journal of andrology 26(3): 
161-165. 
 
Lenton, E.A., Sulaiman, R., Sobowale, O., and Cooke, I.D. 1982. The human 
menstrual cycle: plasma concentrations of prolactin, LH, FSH, oestradiol and 
progesterone in conceiving and non-conceiving women. J Reprod Fertil 65, 
131-139. 
 
Niall HD. 1972. The Chemistry of the Human Lactogenic Hormones. In: Boyns 
AR, Griffiths K, editors. Prolactin and Carcinogenesis: Proceedings of the 
Fourth Tenovus Workshop; March; Cardiff, Wales. Cardiff: Alpha Omega 
Alpha,:1320. 
 
Pacifici, R., Altieri, I., Gandini, L., Lenzi, A., Pichini, S., Rosa, M., Zuccaro, P.,   
Dondero, F., 1993. Nicotine, cotinine, and trans-3- hydroxycotinine levels in 
seminal plasma of smokers: effects on sperm parameters. There Drug Monit.15, 
358363. 
 
Pacifici R, Altieri I, Gandini L, Lenzi A, Passa AR, Pichini S, et al. 1995. 
Environmental tobacco smoke: nicotine and cotinine concentration in semen. 
Environ Res;68(1):6972. 
 
Pierce JG, Parsons TF. 1981. Glycoprotein Hormones: Structure and  Function. 
Annu Rev Biochem;50:46595. 
 
Quitters Guide.2008 smoking and male fertility. 
58 
 
Ramlau-Hansen1, A.M.Thulstrup, A.S.Aggerholm, M.S.Jensen, G.Toft and 
J.P.Bonde. 2007. Is smoking a risk factor for decreased semen quality? A 
cross-sectional analysis. Vol.22, No.1 pp. 188196. 
 
Robert Künzle, M.D.a, Michael D Mueller, M.D.a, Willy Hänggi, M.D.a, Martin 
H Birkhäuser, M.D.a, Heinz Drescher, M.D.b, Nick A Bersinger, Ph.D. 2003. 
Semen quality of male smokers and nonsmokers in infertile couples. Volume 
79, Issue 2, Pages 287-291. 
 
Santen, R.J., and Bardin, C.W. 1973. Episodic luteinizing hormone secretion in 
man. Pulse analysis, clinical interpretation, physiologic mechanisms. J Clin 
Invest 52, 2617-2628. 
 
Schanbacher, B. 1982. Hormonal interrelationships between hypothalamus, 
pituitary and testis of rams and bulls. Journal of Animal Science 55, 56. 
 
Sherman J.Silber,M.D.August1991. Effect of Age on Male Fertility Seminars in 
Reproductive Endocrinology. Volume, Number 3. 
 
Steger, K., Aleithe, I., Behre, H., and Bergmann, M. 1998. The proliferation of 
spermatogonia in normal and pathological human seminiferous epithelium: an 
immunohistochemical study using monoclonal antibodies against Ki-67 protein 
and proliferating cell nuclear antigen. Mol Hum Reprod 4, 227-233. 
 
Steger, K., Fink, L., Failing, K., Bohle, R.M., Kliesch, S., Weidner, W., and   
Bergmann, M. 2003. Decreased protamine-1 transcript levels in testes from  
infertile men. Mol Hum Reprod 9, 331-336. 
 
Talwalker PK, Ratner A, Meites J. 1963. In Vitro Inhibition of Pituitary Prolactin 




Taszarek-H G, Depa-Martynów M, Derwich K, Pawelczyk L, Jedrzejczak P. 
2005. The influence of cigarette smoking on sperm quality of male smokers and 
nonsmokers in infertile couples. 62(10):978-81. 
 
Tiez, N. 1986. Textbook of clinical chemistry. Philadelphia, WB Saunders 
Company. 
Tietz, N. 1995. Clinical guide to laboratory tests (WB Saunders Co). 
Vincenzo Mirone, Cairo Imbimbo, Angela Bortolotti, Elisabetta Di Cintio, Enrico 
Colli, Marina Landoni, Maurizio Lavezzari and Fabio Parazzini. 2002. Cigarette 
smoking as risk factor for erectile dysfunction: results for an Italian 
epidemiological study. European urology volume 41, Issue 3, Pages 294-297. 
Vitt, V., Kloosterboer, H., Rose, U., Bete, S., and Nayudu, P. 1998. Human 
follicle-stimulating hormone isoform fractions differentially affect both the 
development of in vitro grown ovarian follicles and the subsequent maturation 
capacity of the oocytes. Biol Reprod 58, 209. 
WHO Laboratory manual for the examination of Human semen and Sperm-
Cervical mucus interaction. 1992. Cambridge University Press, 3rd edition,  
Wong WY, Thomas CM, Merkus HM, Zielhuis GA, Doesburg WH, Steegers-    
Theunissen RP. 2000. Cigarette smoking and the risk of male factor subfertility: 










Zenzes,.32.Zenzes MT. 2000. Smoking and reproduction: gene damage to 
human gametes and embryos. Human Reproduction, MEDLINE Cross Ref.   
Update.2000;6:122131.  
 
Zirkin, B., and Chen, H. 2000. Regulation of Leydig cell steroidogenic function 































                       
62 
 




                                                                             
Yes                       No 
Personal data 
 
1- Age ----------------- 
 




If yes , since ------------ 
If yes, Do you have children 
 
 
No. of children ----------- 
 
3- Education 
University   Secondary  Preparatory 
 
Primary   Illiterate  
 
4- Occupation 
Employed   Unemployed 
    







Yes                        No 
Medical history  
                                           
5- Do you have history of other disease? 
 
 
   
 If yes define the disease --------------------------- 
 
 And numerate drugs if present---------------,-------------------,---------------- 
                                     








If there are another operations numerate them -------------,----------------, ----------                            
 




9- Did you check your sperm before? 
 
 
If yes, when---------- 
10- Did you check your testosterone, FSH and LH hormones before?  
 
 
If yes, when---------- 
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Yes                         No 
Smoking  data                                          
11- Are you a smoker?                    
 
 
 If yes  
Cigarette  Narjela  Pipe   
 
If cigarette (No. of cigarette/day) 
 
<10 (Light)   10-20 (Moderate)  >20 Heavy                             
 
If Narjela (Times/day) 
 
One    two   >two 
 
If Pipe  (Times/ day) 
 
One    two   >two 
                                         
12- How long you have been smoked? 
   
 <5 years   5-15 years   >15 years      
 
13- Does your wife smoke? 
   
    
 
14- Is the nature of your profession resulting any kind of gas? 






Yes                       No 
 




16- Have you noticed that there is a negative impact of smoking on erectile 
      Function?                   
 
                                                     
17- Do you sit down just next to the smokers? 
 
                                        
 




    If yes, numerate them ------------------ , -----------------------,-------------------------- 
 
 
 
 
 
 
 
 
 
 
 
 
